334
Views
4
CrossRef citations to date
0
Altmetric
Editorial

The ODAC Chronicles: Part 3. The FDA’s philosophy and process for cancer drug evaluation and approval

Pages 1-5 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Antonio J Grillo-López. (2010) The USA’s healthcare debacle: the role of the US FDA. Expert Review of Anticancer Therapy 10:5, pages 607-608.
Read now
Antonio J Grillo-López. (2005) The ODAC Chronicles: Part 7. Tale of two goals. Expert Review of Anticancer Therapy 5:6, pages 939-941.
Read now
Antonio J Grillo-López. (2005) The ODAC Chronicles: Part 6b. ODAC’s structure and function. Expert Review of Anticancer Therapy 5:5, pages 753-756.
Read now

Articles from other publishers (1)

Antonio J. Grillo-López. 2009. Principles of Cancer Biotherapy. Principles of Cancer Biotherapy 613 629 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.